We Are Campaign
Health care in our province is changing. The We Are campaign presents a once-in-a-generation opportunity. Will you step up in the name of better health care?
Funding Atlantic Canada’s first surgical robotics technology, providing the most advanced, minimally-invasive surgeries for prostate, kidney, gynecological and ear, nose and throat (ENT) cancers.
Funding a world’s first cancer-fighting technology and its accompanying research that has the potential to reduce radiation treatments from 25 to 5 for certain cancers and transform cancer care on a global scale.
Equipping Atlantic Canada’s first hybrid operating room with the most leading-edge technology – combining the features of a standard OR, a cardiac catheterization lab and an imaging suite.
Fueling the purchase of Canada’s second orthopaedic surgical robot and its accompanying research, providing robot-assisted knee and hip replacements customized for each patient’s anatomy.
Funding Atlantic Canada's first-ever CAR-T therapy lab at the QEII; a state-of-the-art space dedicated to preparing this lifesaving immunotherapy which is a final lifeline for certain blood cancer patients who’ve tried all other treatment options.
Doubling preparation capacity and unlocking access to more clinical trials by funding equipment and technology within this leading-edge space where all chemotherapy and systemic therapy doses are prepared for QEII patients.
Equipping the QEII’s expanded IR suites with advanced technology for more minimally-invasive procedures than ever before and a new dedicated recovery area – impacting patients with stroke, cancer and more.
Unlocking precision beyond the human hand with robotics technology that helps surgeons place electrodes within the brain – allowing them to pinpoint the exact location of a patient’s seizures for future treatments.
Purchasing a best-in-class genetic sequencing machine that can help inform how a patient’s cancer might progress and the most effective treatment options.
Supporting Nova Scotia’s first hospital-based rTMS clinics in Dartmouth and Kentville, providing free access for patients with treatment-resistant depression.
Introducing same-day, virtual treatment options for those requiring mild to moderate mental health care – providing 24/7 access across Nova Scotia.
Ensuring the most state-of-the-art PET-CT imaging technology is available, allowing teams to detect smaller traces of cancer and significantly improve diagnostic imaging wait times.
Transforming the QEII’s soon-to-open Psychiatric Emergency Care Suites, providing a more comforting and non-stigmatizing environment for those facing mental health crises.
Outfitting the QEII’s Gynecoloscopy Clinic with minimally-invasive detection tools to diagnose and prevent cervical cancer.
Acquiring new diagnostic imaging technology that will reduce wait times for patients during their rehabilitation journey, while supporting training opportunities for the next generation of medical technologists.
Introducing Atlantic Canada’s first gallium dotatate technology to detect and evaluate neuroendocrine tumours with unparalleled accuracy.
Supporting a pan-Canadian research project to accelerate precision medicine for Atlantic Canadian cancer patients, as part of a national Terry Fox Research Institution initiative.
Introducing a text-based, e-Mental health tool that sends automated, daily text messages to people currently accessing mental health services across Nova Scotia.
Empowering young people to actively get involved and share their solution-focused ideas on improving mental health supports.
The We Are campaign was born out of a once-in-a-generation opportunity when the government made a commitment to redevelop the QEII. The new QEII will have an increased number of beds and operating rooms, a new emergency department, and floors upon floors of new space for cancer and ambulatory care. The QEII will also continue to expand its reach into the community to offer its services, increasing access to care.
Our donors make change happen. Learn how you can join our community today.